|
List of Figures and Tables |
|
|
xi | |
| Acronyms |
|
xiii | |
| Preface |
|
xv | |
| Acknowledgments |
|
xix | |
|
Chapter 1 Introduction to Quality Risk Management |
|
|
1 | (22) |
|
1.1 What Is Quality Risk Management? |
|
|
1 | (3) |
|
1.2 Taste of Raspberries, Taste of Death: The 1937 Elixir Sulfanilamide Incident |
|
|
4 | (6) |
|
|
|
10 | (1) |
|
|
|
11 | (3) |
|
FDA's Strategic Action Plan |
|
|
13 | (1) |
|
Risk-Based Model for Inspectional Oversight |
|
|
13 | (1) |
|
|
|
13 | (1) |
|
Aseptic Processing Guidance |
|
|
13 | (1) |
|
1.5 More Than Safety Risks: From Safety Risks to Quality by Design (QbD) |
|
|
14 | (3) |
|
|
|
14 | (1) |
|
|
|
15 | (1) |
|
Design Controls for Medical Devices |
|
|
16 | (1) |
|
|
|
17 | (2) |
|
1.7 Historical Perspective and Current Situation |
|
|
19 | (4) |
|
Chapter 2 Current Initiatives |
|
|
23 | (28) |
|
|
|
23 | (2) |
|
2.2 Drugs and Biotechnology Products |
|
|
25 | (8) |
|
|
|
25 | (1) |
|
|
|
26 | (5) |
|
2.2.3 REMS and Medication Guides |
|
|
31 | (2) |
|
|
|
33 | (10) |
|
|
|
33 | (2) |
|
|
|
35 | (4) |
|
2.3.3 Non-U.S. Regulations |
|
|
39 | (4) |
|
2.4 Food Safety: ISO 22000:2005 and Hazard Analysis and Critical Control Points (HACCP) |
|
|
43 | (2) |
|
2.5 Supply Chain: Risk Consideration for Regulated Products |
|
|
45 | (6) |
|
Chapter 3 Principles of Quality Risk Management |
|
|
51 | (10) |
|
3.1 Principles of Quality Risk Management |
|
|
51 | (4) |
|
|
|
54 | (1) |
|
Full Accountability for Risks |
|
|
54 | (1) |
|
Application of Risk Management in All Decision Making |
|
|
54 | (1) |
|
|
|
55 | (1) |
|
Full Integration in the Organization's Governance Structure |
|
|
55 | (1) |
|
3.2 Science and Risk-Based Approach to Product Quality |
|
|
55 | (3) |
|
3.3 Quality Systems Approach |
|
|
58 | (3) |
|
Chapter 4 General Quality Risk Management Process |
|
|
61 | (22) |
|
4.1 Introduction to Quality Risk Management Process |
|
|
61 | (2) |
|
4.2 Responsibilities and Initiation of the Risk Management Process |
|
|
63 | (2) |
|
|
|
65 | (10) |
|
4.3.1 Risk Identification |
|
|
65 | (2) |
|
|
|
67 | (6) |
|
|
|
73 | (2) |
|
|
|
75 | (2) |
|
|
|
76 | (1) |
|
|
|
77 | (1) |
|
4.5 Risk Documentation and Communication |
|
|
77 | (1) |
|
4.6 Risk Monitoring and Effectiveness Review |
|
|
78 | (1) |
|
4.7 Application of Risk Assessment During Life Cycle Phases |
|
|
79 | (1) |
|
4.8 Enhanced Risk Management |
|
|
80 | (3) |
|
|
|
81 | (1) |
|
Full Accountability for Risks |
|
|
81 | (1) |
|
Application of Risk Management in All Decision Making |
|
|
81 | (1) |
|
|
|
81 | (1) |
|
Full Integration in the Organization's Governance Structure |
|
|
82 | (1) |
|
Chapter 5 Integration of Risk Management with Quality Management |
|
|
83 | (24) |
|
5.1 Risk Management Plans |
|
|
83 | (5) |
|
|
|
84 | (1) |
|
5.1.2 Assignment of Responsibilities and Authorities |
|
|
85 | (1) |
|
5.1.3 Requirements for Review of Risk Management Activities |
|
|
85 | (1) |
|
5.1.4 Criteria for Risk Acceptability |
|
|
85 | (1) |
|
5.1.5 Verification Activities |
|
|
85 | (1) |
|
5.1.6 Methods of Obtaining Relevant Post-Production Information |
|
|
86 | (1) |
|
5.1.7 Example of Risk Management Plan Applied to Medication Guides |
|
|
86 | (2) |
|
5.2 Risk-Based CAPA System |
|
|
88 | (6) |
|
5.3 Examples of Integration between Risk Management and other Quality Management Tools |
|
|
94 | (13) |
|
5.3.1 The Process Analytical Technology (PAT) Approach |
|
|
94 | (5) |
|
5.3.2 Risk-Based Inspection Site Selection |
|
|
99 | (5) |
|
5.3.3 The Quality System Inspection Technique (QSIT) |
|
|
104 | (3) |
|
Chapter 6 Methodologies and Tools |
|
|
107 | (30) |
|
6.1 Selection and Types of Risk Assessment Techniques |
|
|
107 | (2) |
|
6.1.1 Availability of Resources |
|
|
108 | (1) |
|
6.1.2 The Nature and Degree of Uncertainty |
|
|
109 | (1) |
|
|
|
109 | (1) |
|
6.2 Application of Risk Assessment During Life Cycle Phases |
|
|
109 | (1) |
|
6.3 Risk Assessment Techniques and Tools |
|
|
110 | (27) |
|
6.3.1 Basic Risk Management Facilitation Methods |
|
|
110 | (4) |
|
6.3.2 Failure Mode and Effects Analysis (FMEA) |
|
|
114 | (4) |
|
6.3.3 Fault Tree Analysis |
|
|
118 | (4) |
|
6.3.4 Hazard Analysis and Critical Control Points (HACCP) |
|
|
122 | (5) |
|
6.3.5 Hazard and Operability Analysis (HAZOP) |
|
|
127 | (3) |
|
6.3.6 Cause-and-Effect Analysis/5 Whys |
|
|
130 | (1) |
|
|
|
131 | (2) |
|
6.3.8 Preliminary Hazard Analysis (PHA) |
|
|
133 | (1) |
|
6.3.9 Risk Ranking and Filtering |
|
|
134 | (2) |
|
6.3.10 Supporting Statistical Tools |
|
|
136 | (1) |
|
Chapter 7 Practical Applications of Quality Risk Management to the Life Science Manufacturing Industry |
|
|
137 | (28) |
|
|
|
137 | (15) |
|
|
|
138 | (1) |
|
|
|
138 | (2) |
|
7.1.3 Regulatory Actions: Recalls and Health Hazard Evaluation |
|
|
140 | (7) |
|
|
|
147 | (1) |
|
7.1.5 Supplier Selection and Control |
|
|
148 | (2) |
|
|
|
150 | (2) |
|
7.2 Documents and Records/Change Management |
|
|
152 | (1) |
|
7.3 Facilities and Equipment |
|
|
153 | (1) |
|
7.4 Design and Development |
|
|
153 | (2) |
|
7.5 Production and Process Control |
|
|
155 | (8) |
|
7.5.1 Trend Analysis and Statistical Process Control |
|
|
156 | (1) |
|
7.5.2 Aseptic Process in the Pharmaceutical Industry |
|
|
157 | (1) |
|
7.5.3 Validations and Revalidations |
|
|
158 | (2) |
|
|
|
160 | (1) |
|
7.5.5 Packaging and Labeling |
|
|
161 | (1) |
|
|
|
162 | (1) |
|
|
|
163 | (2) |
| Appendix A General Examples |
|
165 | (10) |
| Appendix B Case Studies |
|
175 | (64) |
| Appendix C Fail-Safe FMEA |
|
239 | (10) |
| Appendix D Useful Web Sites |
|
249 | (2) |
| Glossary |
|
251 | (4) |
| Bibliography |
|
255 | (4) |
| Index |
|
259 | |